Location: Las Vegas, NV
CIK: 0002106939 · Show all filings
Period: Q3 2026 (← Previous)
Filing Date: Oct 21, 2026
Total Value: $146M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| SERA | SERA PROGNOSTICS INC | 2,396,685 | $5.009M | 3.4% | $2.09 | $2.05 | +1.9% | CLASS A COM | 81749D107 |
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| IRON | DISC MEDICINE INC | 8,000 | $585K | 0.4% | $73.14 * | $69.40 | -5.7% | — | 254604101 |
| RAPP | RAPPORT THERAPEUTICS INC | 14,000 | $583K | 0.4% | $41.67 * | $27.68 | +21.4% | — | 75383L102 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 17,000 | $568K | 0.4% | $33.39 * | $22.52 | -33.3% | — | 90400D108 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 23,000 | $557K | 0.4% | $24.20 * | $19.12 | -37.6% | — | 61225M102 |
| IONS | IONIS PHARMACEUTICALS INC | 6,800 | $539K | 0.4% | $79.29 * | $75.30 | -40.7% | — | 462222100 |
| PHVS | PHARVARIS N V | 15,000 | $519K | 0.4% | $34.58 * | $24.09 | +31.7% | — | N69605108 |
| ACAD | ACADIA PHARMACEUTICALS INC | 19,766 | $500K | 0.3% | $25.30 * | $23.90 | -15.7% | — | 004225108 |
| PTCT | PTC THERAPEUTICS INC | 6,000 | $489K | 0.3% | $81.57 * | $72.67 | -10.9% | — | 69366J200 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 13,000 | $484K | 0.3% | $37.21 * | $26.34 | +23.1% | — | 15117B202 |
| COGT | COGENT BIOSCIENCES INC | 12,000 | $464K | 0.3% | $38.70 * | $28.11 | +13.9% | — | 19240Q201 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 1,465 | $441K | 0.3% | $301.03 * | $432.30 | -42.9% | — | 02043Q107 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 11,000 | $412K | 0.3% | $37.42 * | $44.52 | +90.8% | — | 22663K107 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 12,000 | $407K | 0.3% | $33.89 * | $36.39 | -33.2% | — | N62509109 |
| LQDA | LIQUIDIA CORPORATION | 5,000 | $399K | 0.3% | $79.73 * | $53.60 | -43.5% | — | 53635D202 |
| VKTX | VIKING THERAPEUTICS INC | 10,000 | $390K | 0.3% | $39.01 * | $35.37 | -7.8% | — | 92686J106 |
| ELVN | ENLIVEN THERAPEUTICS INC | 7,000 | $355K | 0.2% | $50.75 * | $27.70 | +65.5% | — | 29337E102 |
| SYRE | SPYRE THERAPEUTICS INC | 4,000 | $355K | 0.2% | $88.78 | $26.13 | +240.7% | — | 00773J202 |
| VERA | VERA THERAPEUTICS INC | 7,000 | $300K | 0.2% | $42.91 * | $35.52 | -9.1% | — | 92337R101 |
| CRSP | CRISPR THERAPEUTICS AG | 5,000 | $273K | 0.2% | $54.54 | $59.89 | -7.6% | — | H17182108 |
| ZYME | ZYMEWORKS INC | 10,000 | $261K | 0.2% | $26.14 | $21.81 | +21.4% | — | 98985Y108 |
| XENE | XENON PHARMACEUTICALS INC | 4,200 | $254K | 0.2% | $60.36 * | $42.00 | -11.4% | — | 98420N105 |
| AXSM | AXSOME THERAPEUTICS INC. | 1,000 | $245K | 0.2% | $244.77 * | $172.73 | +6.8% | — | 05464T104 |
| AVBP | ARRIVENT BIOPHARMA INC | 7,041 | $245K | 0.2% | $34.74 * | $29.51 | +2.6% | — | 04272N102 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 971 | $234K | 0.2% | $240.97 * | $219.08 | +5.7% | — | G50871105 |
| KOD | KODIAK SCIENCES INC | 6,000 | $234K | 0.2% | $38.96 * | $20.48 | +362.9% | — | 50015M109 |
| BBIO | BRIDGEBIO PHARMA INC | 3,000 | $223K | 0.2% | $74.48 * | $65.64 | +0.2% | — | 10806X102 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 2,000 | $222K | 0.2% | $111.03 * | $90.41 | +5.3% | — | 76243J105 |
| DNLI | DENALI THERAPEUTICS INC | 8,463 | $218K | 0.1% | $25.72 * | $20.55 | +0.6% | — | 24823R105 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 2,600 | $212K | 0.1% | $81.51 * | $73.86 | -11.4% | — | 04280A100 |
| SRRK | SCHOLAR ROCK HLDG CORP | 3,827 | $210K | 0.1% | $55.00 * | $48.31 | +0.0% | — | 80706P103 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 10,838 | $195K | 0.1% | $17.96 * | $13.58 | +114.2% | — | 03237H101 |
| EYPT | EYEPOINT INC | 10,000 | $143K | 0.1% | $14.30 * | $14.17 | -76.9% | — | 30233G209 |
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| XBI | SPDR SERIES TRUST | 386,500 (-32.2%) | $60.94M (-32.4%) | 41.8% | $157.68 | $130.01 | +21.3% | ST STR SP BIOT | 78464A870 |
| INCY | INCYTE CORP | 2,000 (-62.3%) | $243K (-59.6%) | 0.2% | $121.35 | $96.76 | +25.4% | COM | 45337C102 |
| TRVI | TREVI THERAPEUTICS INC | 15,000 (-50.0%) | $215K (-61.6%) | 0.1% | $14.32 | $11.19 | +27.9% | COM | 89532M101 |
| RPRX | ROYALTY PHARMA PLC | 5,000 (-54.5%) | $292K (-52.7%) | 0.2% | $58.36 | $38.13 | +53.0% | SHS CLASS A | G7709Q104 |
| NRIX | NURIX THERAPEUTICS INC | 12,000 (-52.0%) | $285K (-53.1%) | 0.2% | $23.71 | $14.37 | +65.0% | COM | 67080M103 |
| ARGX | ARGENX SE | 300 (-53.2%) | $288K (-51.6%) | 0.2% | $958.91 | $854.69 | +12.2% | SPONSORED ADR | 04016X101 |
| DYN | DYNE THERAPEUTICS INC | 10,000 (-50.0%) | $161K (-63.7%) | 0.1% | $16.11 | $18.94 | -14.9% | COM | 26818M108 |
| TGTX | TG THERAPEUTICS INC | 5,000 (-50.0%) | $279K (-49.2%) | 0.2% | $55.78 | $32.66 | +70.8% | COM | 88322Q108 |
| IMCR | IMMUNOCORE HLDGS PLC | 7,000 (-53.8%) | $212K (-55.9%) | 0.1% | $30.29 | $35.16 | -13.9% | ADS | 45258D105 |
| AUPH | AURINIA PHARMACEUTICALS INC | 15,000 (-50.0%) | $243K (-52.3%) | 0.2% | $16.20 | $14.18 | +14.2% | COM | 05156V102 |
| IMVT | IMMUNOVANT INC | 7,000 (-46.2%) | $236K (-52.8%) | 0.2% | $33.78 | $22.30 | +51.5% | COM | 45258J102 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 10,000 (-49.2%) | $264K (-48.8%) | 0.2% | $26.43 | $25.60 | +3.3% | COM | 03969K108 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 1,800 (-40.0%) | $255K (-49.5%) | 0.2% | $141.84 | $144.51 | -1.8% | COM | 64125C109 |
| KYMR | KYMERA THERAPEUTICS INC | 2,000 (-50.0%) | $224K (-51.3%) | 0.2% | $111.79 | $67.53 | +65.5% | COM | 501575104 |
| DFTX | DEFINIUM THERAPEUTICS INC | 6,500 (-35.0%) | $247K (-47.4%) | 0.2% | $38.06 | $16.97 | +124.3% | COM SHS | 24477V105 |
| HALO | HALOZYME THERAPEUTICS INC | 3,000 (-57.1%) | $331K (-39.5%) | 0.2% | $110.40 | $67.27 | +64.1% | COM | 40637H109 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 12,000 (-40.0%) | $226K (-48.4%) | 0.2% | $18.80 | $17.45 | +7.8% | COM | 87164F105 |
| ARDX | ARDELYX INC | 30,000 (-50.0%) | $103K (-66.5%) | 0.1% | $3.42 | $6.62 | -48.3% | COM | 039697107 |
| ASND | ASCENDIS PHARMA A/S | 1,000 (-33.3%) | $228K (-43.1%) | 0.2% | $227.83 * | $233.60 | +12.8% | ORD SHS | K08588103 |
| TARS | TARSUS PHARMACEUTICALS INC | 3,500 (-50.0%) | $275K (-37.6%) | 0.2% | $78.61 | $74.33 | +5.8% | COM | 87650L103 |
| STOK | STOKE THERAPEUTICS INC | 9,000 (-25.0%) | $234K (-40.4%) | 0.2% | $26.00 | $30.06 | -13.5% | COM | 86150R107 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 1,500 (-50.0%) | $211K (-42.5%) | 0.1% | $140.89 | $81.85 | +72.1% | COM | 74366E102 |
| EXEL | EXELIXIS INC | 5,000 (-37.5%) | $292K (-32.9%) | 0.2% | $58.41 | $41.37 | +41.2% | COM | 30161Q104 |
| CMPS | COMPASS PATHWAYS PLC | 10,000 (-44.4%) | $124K (-51.2%) | 0.1% | $12.44 | $6.73 | +85.0% | SPONSORED ADS | 20451W101 |
| IMNM | IMMUNOME INC | 12,000 (-33.3%) | $258K (-32.3%) | 0.2% | $21.51 | $17.55 | +22.6% | COM | 45257U108 |
| HRMY | HARMONY BIOSCIENCES HLDGS IN | 7,000 (-30.0%) | $275K (-24.5%) | 0.2% | $39.26 | $32.88 | +19.4% | COM | 413197104 |
| KNSA | KINIKSA PHARMACEUTICALS INTL | 3,500 (-30.0%) | $261K (-18.3%) | 0.2% | $74.61 | $40.11 | +86.0% | ORD SHS CL A | G52694109 |
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| NTLA | INTELLIA THERAPEUTICS INC | 20,000 | $241K | 0.2% | $12.06 | $12.72 | -5.2% | COM | 45826J105 |
| MIRM | MIRUM PHARMACEUTICALS INC | 2,500 | $214K | 0.1% | $85.48 | $71.78 | +19.1% | COM | 604749101 |
| ALKS | ALKERMES PLC | 6,000 | $243K | 0.2% | $40.52 | $29.95 | +35.3% | SHS | G01767105 |
| TNGX | TANGO THERAPEUTICS INC | 10,000 | $250K | 0.2% | $24.95 | $13.93 | +79.1% | COM | 87583X109 |
| CTMX | CYTOMX THERAPEUTICS INC. | 39,400 | $107K | 0.1% | $2.72 | $3.82 | -28.8% | COM | 23284F105 |
| OLMA | OLEMA PHARMACEUTICALS INC | 10,000 | $86,400 | 0.1% | $8.64 | $17.79 | -51.4% | COM | 68062P106 |
| ORKA | ORUKA THERAPEUTICS INC | 3,000 | $250K | 0.2% | $83.29 | $34.76 | +139.6% | COM | 687604108 |
| ORIC | ORIC PHARMACEUTICALS INC | 13,000 | $175K | 0.1% | $13.47 | $11.35 | +18.7% | COM | 68622P109 |
| OCUL | OCULAR THERAPEUTIX INC | 15,000 | $115K | 0.1% | $7.67 | $12.15 | -36.9% | COM | 67576A100 |
| KRYS | KRYSTAL BIOTECH INC | 692 | $230K | 0.2% | $332.56 | $298.78 | +11.3% | COM | 501147102 |
| DNTH | DIANTHUS THERAPEUTICS INC | 2,500 | $220K | 0.2% | $88.05 | $38.77 | +127.1% | COM | 252828108 |
| RVMD | REVOLUTION MEDICINES INC | 1,200 | $246K | 0.2% | $205.26 | $146.07 | +40.5% | COM | 76155X100 |
| SUPN | SUPERNUS PHARMACEUTICALS | 6,000 | $258K | 0.2% | $43.04 | $48.62 | -11.5% | COM | 868459108 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 600 | $302K | 0.2% | $503.96 | $510.76 | -1.3% | COM | 558868105 |
| SGOV | ISHARES TR | 700,000 | $70.48M | 48.3% | $100.68 | $100.50 | +0.2% | 0-3 MTH TREASURY | 46436E718 |
| EWTX | EDGEWISE THERAPEUTICS INC | 5,000 | $203K | 0.1% | $40.60 | $28.84 | +40.8% | COM | 28036F105 |